Iloperidone (Mylan Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the Iloperidone drug offered from Mylan Pharmaceuticals Inc.. This Atypical Antipsychotic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Mylan Pharmaceuticals Inc.
NON-PROPRIETARY NAME: Iloperidone
SUBSTANCE NAME: ILOPERIDONE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Atypical Antipsychotic [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-03-20
END MARKETING DATE: 0000-00-00


Iloperidone HUMAN PRESCRIPTION DRUG Details:

Item DescriptionIloperidone from Mylan Pharmaceuticals Inc.
LABELER NAME: Mylan Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/1)
START MARKETING DATE: 2017-03-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0378-0630_9e1900e4-eae1-4295-826c-d598e3486e5a
PRODUCT NDC: 0378-0630
APPLICATION NUMBER: ANDA207231

Other ILOPERIDONE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalFANAPT
Mylan Pharmaceuticals Inc.Iloperidone
Novartis Pharmaceuticals CorporationFANAPT
Vanda Pharmaceuticals Inc.Fanapt